基本信息
浏览量:12
职业迁徙
个人简介
Jan M. Keppel Hesselink, MD, MSc, PhD received his MSc in biology (cum laude) at the university of Utrecht; his degree in medicine, MD in Utrecht, his PhD (thesis on Parkinson's disease) at the university of Nijmegen, NL.
In 1996 he was appointed professor of molecular pharmacology at the university of Witten/Herdecke (Germany).
He became a member of the British association of psychopharmacology (MBAP) and in the same period he was elected as Fellow of the Pharmaceutical Faculty in Medicine (FFPM) in the UK.
He worked several years at Bayer AG in Germany as VP CNS and business head CNS. He was director at Licentec and advisor scientific R&D as well as business strategies to the Dutch Royal Acadamy of Science (KNAW) and KNAW institutes, such as the Hubrecht Institute, were he assisted spin-outs.
In 2009 he started the Institute for neuropathic pain. Since then 8 different novel topical analgesic creams have been developed, the most recent one based on phenytoin, protected by 2 patents in the PTC phase.
He is currently a consultant for the pharma industry and advices life science investors by conducting DD on IP and coach spin-outs and spin-offs in the R&D focussed on registration NCE's.
研究兴趣
论文共 83 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jan M Keppel Hesselink, Stephen M Stahl
Journal of Mood Disorders and Therapyno. 1 (2019)
Clinical sciences research and reportsno. 1 (2019)
加载更多
作者统计
#Papers: 83
#Citation: 985
H-Index: 20
G-Index: 28
Sociability: 4
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn